Asked on Healicus
Is fish oil still worth taking for heart health?
Answer published by a reader on . AI-generated from the sources below; general educational information, not medical advice.
Fish oil supports normal heart function but hasn't been shown to prevent heart attacks or strokes in the general population — and at high doses it may actually raise the risk of atrial fibrillation.
Here's where the evidence lands:
- The EU authorises a claim that EPA + DHA contribute to normal heart function at 250 mg/day combined — a maintenance claim, not a disease-prevention one.
- NICE (2023) explicitly advises against offering omega-3 compounds to prevent cardiovascular disease, with one narrow exception: icosapent ethyl added to statins for people with very high triglycerides.
- A large randomised trial in haemodialysis patients (4 g/day of EPA + DHA vs. placebo) found no significant reduction in serious cardiovascular events in that high-risk group 1Lok CE et al., N Engl J Med, 2026 — Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving HemodialysisRandomised trial · N Engl J Med 2026The rate of serious cardiovascular events among participants receiving maintenance hemodialysis was lower with daily supplementation with n-3 fatty acids than with placebo. (Supported by the Heart and Stroke Foundation of Canada and others; PISCES ClinicalTrials.gov number, ISRCTN00691795.).Open on pubmed.ncbi.nlm.nih.gov ↗.
- At prescription doses (4 g/day), the EMA flagged atrial fibrillation as a dose-dependent risk.
The practical upshot: if you eat fatty fish twice a week or more, supplements add little. If you don't, 1–2 g/day of combined EPA + DHA is a reasonable way to meet the baseline intake the EU claim is based on — not as a heart-attack preventer, but as nutritional support for normal cardiac function. The blood-thinning effect is mild but worth mentioning to a doctor if you're on anticoagulants.
Sources
In this answer
Have a follow-up, or a question of your own? Every answer cites Cochrane, EU regulators, guideline bodies or trials in leading journals.